mechanism hormone disease (lec 3).ppt

download mechanism hormone disease (lec 3).ppt

of 92

Transcript of mechanism hormone disease (lec 3).ppt

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    1/92

    1

    Mechanisms of endocrine disease

    Endocrine disorders result from hormonedeficiency, hormone excess or hormone

    resistance

    Almost without exception, hormonedeficiency causes disease

    One notable exception is calcitonin

    deficiency

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    2/92

    2

    Cellular Mechanisms of Hormone Action

    Target cellrecognize, bind and

    initiate

    Up regulation

    Down regulation

    Hormone effects

    Direct stimulation Permissive facilitates maximum

    response/function

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    3/92

    3

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    4/92

    4

    Deficiencyusually is due to destructiveprocess occurring at gland in which hormone

    is producedinfection, infarction, physical

    compression by tumor growth, autoimmune

    attack

    Mechanisms of endocrine disease

    Type I Diabetes

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    5/92

    5

    Deficiency can also arise from geneticdefects in hormone productiongene

    deletion or mutation, failure to cleave

    precursor, specific enzymatic defect (steroid

    or thyroid hormones)

    Mechanisms of endocrine disease

    Congenital Adrenal Hyperplasia

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    6/92

    6

    Inactivating mutations of receptors cancause hormone deficiency

    Mechanisms of endocrine disease

    Testicular Feminization Syndrome

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    7/92

    7

    Hormone excess usually results in disease Hormone may be overproduced by gland

    that normally secretes it, or by a tissue that

    is not an endocrine organ. Endocrine gland tumors produce hormone in

    an unregulated manner.

    Mechanisms of endocrine disease

    Cushings Syndrome

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    8/92

    8

    Exogenous ingestionof hormone is thecause of hormoneexcessfor example,glucocorticoid excessor anabolic steroidabuse

    Mechanisms of endocrine disease

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    9/92

    9

    Activating mutations of cell surface receptorscause aberrant stimulation of hormoneproduction by endocrine gland.

    McCune-Albright syndrome usually

    caused by a mutation in a gene calledGNAS1 (Guanine Nucleotide bindingprotein, Alpha Stimulating activitypolypeptide 1).

    Mechanisms of endocrine disease

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    10/92

    10

    Malignant transformation of non-endocrine tissue causesdedifferentiation and ectopic productionof hormones

    Anti-receptor antibodies stimulatereceptor instead of block it, as in thecase of the common form of

    hyperthyrodism.

    Mechanisms of endocrine disease

    Graves Disease

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    11/92

    11

    Alterations in receptor number and functionresult in endocrine disorders

    Most commonly, an aberrant increase in the

    level of a specific hormone will cause adecrease in available receptors

    Mechanisms of endocrine disease

    Type II diabetes

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    12/92

    12

    Adrenal Gland

    Adrenal glands are located on the top of both kidneys.

    Each gland consists of a medulla, the center of the

    gland, encased by a cortex.

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    13/92

    13

    Adrenal Glands Adrenal cortex

    80%of an adrenal glands total weight

    Zona glomerulosaaldosterone 15%

    Zona fasciculataglucocorticoids 78%

    Zona reticularisandrogens and estrogens(others)

    7%

    Adrenal medulla

    Innervation by SNS

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    14/92

    14

    Adrenal Glands

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    15/92

    15

    -Inner part medulla:

    -Chromaffin cells-Source of catecholamines (Epi/NEpi),

    -Innervated by pre-ganglionic sympathetic fibers; forms an

    extension of the sympathetic nervous system (fight/flight).

    -Outer part cortex:

    -Source of steroid hormones

    -Glucocorticoids, mineralocorticoids and sex steroids

    Anatomy/Physiology of Adrenal Gland

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    16/92

    16

    DHBR

    NADP+NADPH

    from phe, diet, or protein

    breakdown

    Tyrosine L-Dopa

    H2OO2

    Tyrosine hydroxylase(rate-determining step)

    BH2BH4

    1

    Dopa

    decarboxylase

    CO2

    Dopamine

    pyridoxalphosphate

    2

    Dopamine hydroxylase

    ascorbateH2O

    Norepinephrine

    O23

    NMT

    SAM SAH

    Epinephrine

    4

    Biosynthesis of catecholamines. BH2/BH4, dihydro/tetrahydrobiopterin;

    DHBR, dihydrobiopterin reductase; NMT, N-CH3 transferase; SAH, S-

    adenosyl-homocysteine; SAM, S-adenosylmethionine

    Parkinsons disease: local

    deficiency of dopamine

    synthesis; L-dopa boostsproductionNMT specific to

    adrenal medulla

    SAM from

    metabolism of

    Met

    DPN OHase in neuro-

    scretory granules

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    17/92

    17

    .....

    ...

    acetylcholine

    Adrenal Medulla

    Chromaffin Cell

    Neuron

    Acute

    regulation

    Tyrosine

    L-DopaDPN

    DPN

    NE

    granuleinduction

    Chronic

    regulation

    Stress

    Hypothalamus

    ACTH

    Cortisolfrom adrenal

    cortex via intra-

    adrenal portal

    system

    EpinephrinePNMT

    NE

    neuro-

    secretory

    granules

    E E E

    NE E

    Regulation of the release of

    catecholamines and synthesis of

    epinephrine in the adrenal medulla

    chromaffin cell.

    promotesexocytosis

    ................

    EEE

    ENEE

    E E

    NE

    E

    Ca2+

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    18/92

    18

    Norepinephrine

    Epinephrine COMT + MAO

    Vanillylmandelic acid

    Figure 3. Degradation of epinephrine, norepinephrine and dopamine via monoamine

    oxidase (MAO) and catechol-O-methyl-transferase (COMT)

    Neuronal re-uptake and degradation of catecholamines quickly

    terminates hormonal or neurotransmitter activity.

    Cocaine binds to dopamine receptor to block re-uptake of dopamine

    Dopamine continues to stimulate receptors of the postsynaptic nerve.

    Dopamine Homovanillic acid

    COMT + MAO

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    19/92

    19

    Classification of Adrenergic Hormone Receptors

    Receptor Agonists SecondMessenger

    G protein

    alpha1 (1) E>NE IP3/Ca2+; DAG Gq

    alpha2 (2) NE>E cyclic AMP Gi

    beta1 (1) E=NE cyclic AMP Gsbeta2 (2) E>>NE cyclic AMP Gs

    E = epinephrine; NE = norepinephrine

    Synthetic agonists:

    isoproterenol binds to beta receptorsphenylephrine binds to alpha receptors (nose spray action)

    Synthetic antagonists:

    propranolol binds to beta receptors

    phentolamine binds to alpha receptors

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    20/92

    20

    Metabolic and muscle contraction responses to catecholamine binding tovarious adrenergic receptors.

    Process 1-receptor(IP3, DAG)

    2-receptor

    ( cAMP)1-receptor

    ( cAMP)2-receptor( cAMP)

    Carbohydrat

    e

    metabolism

    liver

    glycogenolysis

    No effect No effect

    liver/muscle

    glycogenolysis;

    liver gluconeogenesis; glycogenesis

    Fat

    metabolismNo effect lipolysis lipolysis No effect

    Hormone

    secretionNo effect

    insulin,renine

    secretion

    No effect insulin, glucagon and

    renin secretion

    Muscle

    contraction

    Smooth

    muscle - blood

    vessels,

    genitourinary

    tractcontraction

    Smooth

    muscle -

    some

    vascular;

    GI tractrelaxation

    Myocardial

    - rate,force

    Smooth muscle

    relaxation - bronchi,

    blood vessels,

    GI tract, genitourinary

    tract

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    21/92

    21

    1 or2receptor

    ATPcyclic AMP

    Gs

    s

    GTP

    inactive

    adenylylcyclase

    GTP

    ACTIVE

    adenylyl

    cyclase

    inactive

    adenylylcyclase

    2 receptor

    Mechanisms of1, 2, and 2 agonist effects on adenylyl cyclase activity

    Gi

    i

    GTPs

    GTP

    i

    X

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    22/92

    22

    " FIGHT OR FLIGHT" RESPONSE

    epinephrine/ norepinephrine major elements in the "fight or flight" response

    acute, integrated adjustment of many complex processes in organs vital to the

    response (e.g., brain, muscles, cardiopulmonary system, liver)

    occurs at the expense of other organs less immediately involved (e.g., skin, GI).

    epinephrine:rapidly mobilizes fatty acids as the primary fuel for muscle action

    increases muscle glycogenolysis

    mobilizes glucose for the brain by hepatic glycogenolysis/gluconeogenesis

    preserves glucose for CNS by insulin release leading to reduced glucoseuptake by muscle/ adipose

    increases cardiac output

    norepinephrine elicits responses of the CV system - blood flow and insulinsecretion.

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    23/92

    23

    ADRENAL CORTEX-DERIVED STEROIDS

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    24/92

    24

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    25/92

    25

    Adrenal Cortex

    all hormones derived from cholesterol Stimulated by adrenocorticotropic hormone (ACTH)

    Glucocorticoid hormones

    Direct effect on carbohydrate metabolism

    Anti-inflammatory and growth suppression effects Influences awareness and sleep habits

    Inhibits bone matrix-protein matrix

    Cortisol most potent naturally occurring

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    26/92

    26

    Adrenal Cortex

    Mineralocorticoid hormones

    Aldosterone Na+ uptake in epithelial cells

    distal nephrons

    Na retention with loss of K+ and H+

    Regulation by the renin-angiotensin

    system

    Na+ and H2O depletion K+ excreteion

    blood volume

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    27/92

    27

    Adrenal Cortex-derived Stero ids

    Class Major Effects

    Glucocorticoids Cortisol Glucose metabolism

    control

    Mineralocorticoids Aldosterone Na/K/H20 control

    Sex steroids DHEA Androgen precursors

    Androstendione

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    28/92

    28

    SECRETION OF INDIVIDUAL

    STEROID HORMONES IS

    RESTRICTED TO SPECIFIC

    REGIONS OF THE ADRENAL

    CORTEX

    CAPSULE

    MEDULLARETICULARIS

    MEDULLA

    SYNTHESIS OF ADRENAL CORTEX HORMONES

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    29/92

    29

    SYNTHESIS OF ADRENAL CORTEX HORMONES

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    30/92

    30

    Hypothalamus

    Anterior pituitary

    Adrenal cortex

    Corticotropin-releasingfactor (CRF)

    Adrenocorticotropic hormone

    (ACTH)

    Glucocorticoids

    (especially cortisol)

    Hypoxia

    Hypoglycemia

    Hyperthermia

    Exercise

    Cortisol

    insufficiency

    Stress

    Diurnal

    rhythms

    ( - )

    Somatostatin

    Hypothalamic

    lesions

    ( - )

    (+)

    (+)(+)

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    31/92

    31

    minusside

    chain

    ALL STEROIDOGENIC TISSUES

    CHOLESTEROL(C27)

    + 3-keto

    + 11-OH

    PROGESTERONE

    +3-keto

    + 21-OH

    + 3-keto

    + 11-OH

    + 21-OH

    + 17-OH

    CORTISOL (C21)

    CORTICOSTERONE

    ALDOSTERONE(C21)

    + 20-keto

    + 17-OH

    PREGNENOLONE(C21)

    ANDROSTENEDIONE(C19)

    + 18-ALDEHYDE

    TESTOSTERONE

    ESTRADIOL (C19)

    GONADS

    ADRENAL CORTEX

    ESTRONE

    STEROID SYNTHESIS

    DEHYDROEPIANDROSTERONE

    DHEA

    17-OH PROGESTERONE

    DEHYDROEPIANDROSTERONESULFATE (C19 :DHEA-S)

    + 3-keto

    aromatase

    17-OH PREGNENOLONE

    DIHYDROTESTOSTERONE (C19)

    sulfotransferasedesmolase

    desmolase

    aromatase

    Adrenals

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    32/92

    32

    ENDOPLASMIC RETICULUM

    OXIDATION OF STEROID NUCLEUS

    BY SPECIFIC P-450 HYDROXYLASES

    ALDOSTERONE

    ANDROGENPRECURSORS

    SYNTHESIS AND SECRETION OF STEROID HORMONES BY ADRENAL CORTEX

    GONADS

    Cholesterol in

    Intracellular

    Lipid droplets

    2

    1

    3

    KIDNEY

    DIFFUSION OF STEROIDS

    OUT OF CELLCORTISOL

    CHOLESTEROL IS TAKEN UP INTO MITOCHONDRIA

    EITHER DIRECTLY FROM PLASMA LDL/HDL OR FROM

    INTRACELLULAR CHOLESTEROL ESTERS STORED

    IN LIPID DROPLETS

    UPTAKE OF CHOLESTEROL

    ESTER FROM LDL AND HDL

    IN PLASMA

    StAR facilitates transfer of

    cholesterol molecules between

    inner and outer membranes

    4

    17-OH PROGESTERONEREMOVAL OFSIDE CHAIN

    P450c11

    11-HYDROXYLASE

    h b l ff f l d

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    33/92

    33

    The metabolic effects of glucocorticoids

    They increase glucose production by:

    1. Increasing the supply of amino acids to the liver2. Activating the expression of genes of gluconeogenic enzyme

    Promote lipolysis in peripheral tissues by inducing enzyme synthesis

    (Increase mobilization of peripheral fat)

    When at very high levels can cause lipogenesis in face and trunk

    When at a very high levels has catabolic effect on proteins in peripheral

    tissues and anabolic effect in the liver

    h b l ff f l d

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    34/92

    34

    The metabolic effects of glucocorticoids

    When at very high levels can cause lipogenesis in face and trunk

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    35/92

    35

    Cortisol (hydrocortisone) and synthetic glucocorticoids(prednisone): Potent anti-inflammatory and

    immunosuppressive agent [topical, oral, aerosolized, injection]

    Therapeutic Effects of Glucocorticoids

    -used to relieve symptoms of inflammation [swelling, heat,

    redness, and pain];

    -used in cases of insufficient synthesis (hormone replacement);

    -used to treat certain forms of arthritis; skin, blood, kidney, eye,thyroid, and intestinal disorders (e.g., colitis); severe allergies; and

    respiratory conditions such as asthma.

    -used in the treatment of certain types of cancer.

    How glucocorticoids suppress immune and inflammatory reactions

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    36/92

    36

    A glucocorticoid interaction with its receptor results in increasing the transcription

    of the protein IB, which binds and inhibits the activity of NF-B, a a transcriptionalactivator that stimulates transcription of genes for inflammatory cytokines. NF-B

    is normally sequestered in an inactive state through association with IB proteins.(TNF is a proinflammatory cytokine.)

    Glucocorticoid induction of

    IB synthesis through GCbinding to its intracellular

    receptor and stimulating trans-

    cription of the gene.

    IB binds toand inhibits the

    nuclear translo-

    cation of NF-B.

    NF-B stimulates theultimate production of

    inflammatory cytokinesTumor necrosis factor (TNF)binding to its receptor leads to

    the ultimate degradation of IB

    How glucocorticoids suppress immune and inflammatory reactions

    mediated by cytokines

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    37/92

    37

    Cortisol (the naturally-occurring glucocorticoid)

    levels are regulated by a hypothalamus-

    pituitary-adrenal hormone axis.

    Corticotropin releasing hormone

    (CRH) controls adrenocortioctropic hormone(ACTH) release from the pituitary.

    ACTH is a trophic hormone that

    stimulates:

    -synthesis and secretion of cortisol and

    -growth of the adrenal gland.

    When cortisol levels increase, CRH and ACTH

    secretion/release are reduced.

    Adrenal Gland Steroids

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    38/92

    38

    Mineralocort ic oids (e.g. aldosterone)-enhance renal tubular retention of Na+, HCO3- and water

    and increase excretion of K+: this increases serum Na and

    decreases serum K

    -increased blood volume and pressure

    Mineralocorticoids

    Removal of the adrenal glands leads to death within just a few days due to:

    -the concentration of potassium in extracelluar fluid becomes dramatically

    elevated;

    -urinary excretion of sodium is high and concentrations of sodium inextracellular fluid decreases significantly;

    -volume of extracellular fluid and blood plummet;

    -the heart begins to function poorly, cardiac output declines and shock ensues

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    39/92

    39

    Control over aldosterone secretion is multifactorial:

    -The two most significant regulators of aldosterone secretion are:

    Concentrations of K+ in extracellular fluid: Small increases in blood

    levels of potassium strongly stimulate aldosterone secretion.

    Angiotensin II: Activation of the renin-angiotensin system as a result of

    decreased renal blood flow (usually due to decreased vascular volume)

    results in release of angiotensin II, which stimulates aldosterone secretion

    Control of Aldosterone Secretion

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    40/92

    40

    Adrenal Insufficiency (Addisons disease, 1:100,000)

    Primary Adrenal Insufficiency:

    -most common cause is autoimmune-mediated destruction of the adrenal

    glands (>80%)

    -secondary to tuberculosis, chronic fungal infections, infection by

    cytomegalovirus (CMV), metastasis to the glands by cancer cells (~20%)

    Secondary Adrenal Insufficiency:

    -Addisons Disease caused by inadequate secretion of ACTH by the

    pituitary gland;-may arise due to the prolonged or improper use of glucocorticoid

    hormones( temporary);

    Disorders of the Adrenal Gland

    Di d f h Ad l Gl d

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    41/92

    41

    Cushings Syndrome

    -Cushing's Syndrome is EITHER a disease caused by anexcess of cortisol production, or a disorder resulting fromexcessive use of glucocorticoids

    Disease-related excess production of cortisol (2 types):

    1) Excess ACTH Production:

    Ex. A pituitary tumorproducing too much ACTH

    stimulates adrenal growth and increases cortisol(>70%); Also "ectopic" ACTH production (30%)

    2) Adrenal cortex tumours: Tumours can be benign

    (an adenoma), or malignant (a carcinoma). Usually

    found on only one side.

    Disorders of the Adrenal Gland

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    42/92

    42

    Stress = any condition that threatens homeostasis

    GAS (General Adaptation Syndrome) is our bodiesresponse to stress-causing factors

    Three phases to GAS

    Alarm phase (immediate, fight or flight, directed

    by the sympathetic nervous system and

    dominated by the catecholamines)

    Resistance phase (dominated by

    glucocorticoids) Exhaustion phase (breakdown of homeostatic

    regulation and failure of one or more organ

    systems)

    Hormones and stress

    The General Adaptation Syndrome

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    43/92

    43

    The General Adaptation Syndrome

    The General Adaptation Syndrome

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    44/92

    44

    The General Adaptation Syndrome

    Figure 18.21

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    45/92

    45

    The General Adaptation Syndrome

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    46/92

    46

    Retinoid Hormones

    Isoprenoid hydrophobichormones.

    The pro-hormone, retinol, ismade in the liver.

    Retinol is converted to the

    hormone, retinoic acid, bymany tissues.

    Retinoic acid regulates cellgrowth and development inmost cells, but the principaltargets are the cornea, skin

    and epithelia.

    Excess Vitamin A can causebirth defects and liverdamage.

    Severe acne is treated with

    retinoid creams.

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    47/92

    47

    THYROID HORMONES

    G

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    48/92

    48

    The Thyroid Gland

    Figure 18.11b, c

    Thyroglobulin is a protein rich in Tyr (100Tyr/1molecule)

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    49/92

    49

    Synthesis of T3 and T4

    The thyro id gland:Synthesizes and secretes triiodothyronine-T3 andthyroxine-T4

    -the only body tissue that can accumulate iodide

    Steps of thyroid hormone synthesis

    -accumulat ion of iod idevia a specific iodide pump.

    -iod inati t ion of tyros ineproduces monoiodotyrosine (MIT) and

    diiodotyrosine (DIT)

    - cou pl ing react ion:Synthesis of MIT/DIT:

    -MIT +DIT produces T3 (3 iodine)-DIT+DIT, T4 (4 iodine).

    -MIT/DIT are complexed with thyroglobulin.

    -Thyroglobin pro teolys isliberates T3 and T4

    - Released hormones are secreted: 5(T4) to

    1(T3).

    SYNTHESIS OF THYROID HORMONES STEP 1 IODINATION

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    50/92

    50

    TYROSINE

    IODINATION

    TYROSINE

    MONOIODOTYROSINE(MIT)

    DIIODOTYROSINE (DIT)

    I

    I

    NH2

    TYROSINE

    IODINATION

    I

    I

    SYNTHESIS OF THYROID HORMONES: STEP 1 - IODINATION

    Approximately 10% of the tyrosine residues on the

    550 amino acid residue Thyroglobulin molecule may

    become iodinated by the enzyme - thyroid

    peroxidase acting on the colloid at the luminal

    surface of the thyroid follicle. These reactions only

    occur in the thyroid at specific residues in

    Hormonogenic sites located at the extreme ends of

    the Thyroglobulin molecule.

    Tyr

    Tyr

    THYROGLOBULIN

    THYROGLOBULIN

    THYROGLOBULIN-

    SYNTHESIS OF THYROID HORMONES: STEP- 2 COUPLING OF IODOTYROSINES

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    51/92

    51

    Thyroglobulin

    CH2CHCOOH

    Thyroglobulin

    I

    I

    Tyr

    3,5,35-tetraiodothyronine

    SYNTHESIS OF THYROID HORMONES: STEP 2 COUPLING OF IODOTYROSINES

    CH2CHCOOH

    NH2+HO

    II

    I

    Tyr

    NH2

    T4

    Thyroglobulin

    I

    I

    Tyr CH2CHCOOH

    NH2

    CH2CHCOOH

    I

    Tyr

    NH2

    Thyroglobulin

    Tyr

    II

    I

    Tyr O+

    IT3

    3,5,3-Triiodothyronine

    Coupling of iodotyrosine moities results in the loss

    of the peptide linkage to thyroglobulin allowing thyroid

    hormones to diffuse across the cell membrane

    II

    Tyr

    II

    I

    Tyr O

    I

    33

    55

    HO

    HO

    HO

    HO

    HO

    3,5,35-tetraiodothyronine

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    52/92

    53

    CH2CHCOOH

    NH2

    CH2CHCOOH

    3,3,5-Triiodothyronine (reverse T3)

    NH2

    Tyr

    II I

    Tyr O

    rT3

    I

    3,5,3-Triiodothyronine (T3)

    II

    Tyr

    II

    I

    Tyr O

    T4I

    T3

    Tyr

    II I

    Tyr O

    I

    5- deiodination5-deiodination

    CH2CHCOOH

    ACTIVATION PATHWAY

    In peripheral tissuesDEACTIVATION PATHWAY

    NH2

    STEP 3DEIODINATION

    SELENODEIODINASES

    SECRETION OF THYROID HORMONE

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    53/92

    54

    TG

    IODINATIONOF THYROGLOBULIN

    BY THYROID PEROXIDASE

    DIFFUSION OF THYROXINE

    THROUGH CELL MEMBRANE

    DEGRADATION OF

    THYROGLOBULIN

    FUSION OF PHAGOSOME

    WITH LYSOSOMES

    ENDOCYTOSIS OF

    COLLOID IN FOLLICLE BY

    PSEUDOPOD

    TG

    TG

    TG

    T4

    T4 T3>> >

    I

    IODIDE UPTAKE

    BY Na/I

    SYMPORTER

    IODIDE IN

    ECF~20nM

    DEGRADATION

    AND

    RECYCLING

    OF MIT/DIT

    BY DEIODINASES FREE THYROXINE RELEASED FROM

    PROTEIN INTO CYTOPLASM

    TG

    2

    1

    3

    4

    5

    6

    7

    8

    Additional metabolism??

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    54/92

    55

    THYROID HORMONES

    HORMONE

    RELATIVE

    POTENCYPRODUCTION

    t(g/day)

    4-8 (24)*

    BOUND TO

    PLASMAPROTEINS

    (%)

    -

    99.95

    (days)

    80- 90 8

    0.04 99.8 0.1

    + + + +

    rT3

    VALUES IN PARENTHESES INDICATE PERIPHERAL CONVERSION

    2-3 (27) *

    1-3

    6-7+T4

    T3

    *

    (g/dL)

    PLASMA

    CONCENTRATION

    0.3 99.7

    R l d T3/T4 R l

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    55/92

    56

    Regulated T3/T4 Release

    T3/T4 synthesis/release is tightly regulated:

    -reduced T3/T4 stimulates TRH release from the

    hypothalamus (HPT) which then causes TSH

    release from the pituitary (PIT).

    TSH stimulates:1) T3/T4 synthesis and secretion

    2) thyroid gland growth.

    When T3/T4 levels increase, negative feedback

    shuts off TRH and TSH secretion.

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    56/92

    57

    Physiological Actions of T3/T4

    Play a Central Role in Regulating :

    -growth/development of most cells,

    -basal metabolic rate and temperature (stimulate cellularrespiration)

    -cardiac output by increasing rate/force of contraction,

    -metabolism of cholesterol to bile acids,

    -LDL receptor expression in hepatocytes,

    -TSH secretion

    THYROID HORMONES ARE ESSENTIAL TO LIFE!

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    57/92

    58

    Symptoms include:fatigue/weakness, weight gain/difficultylosing weight, coarse/dry hair, dry/rough pale skin, cold intolerance,

    muscle cramps/muscle aches, constipation, depression, irritability,

    memory loss, abnormal menstrual cycles, decreased libido

    -Myxedema coma:A medical emergency characterized byhypothermia, hypotension, hypoventilation and bradycardia

    represents the extreme expression of severe hypothyroidism

    Hypothyroidism (Myxedema)

    Reduced circulating T3/T4 levels

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    58/92

    59

    Problems with the Thyroid Gland

    Hyperthyroidism:

    high metabolic rate, hyperactivity, sensitivity to heat, protruding eyes Graves disease: when hyperthyroidism is due to an autoimmune problem

    (TSH is mimicked by autoantibodies)

    Hypothyroidism:

    in the adult: myxedema- low metabolic rate, sensitivity to cold,sluggishness, weight gain/difficulty losing weight, coarse/dry hair, dry/roughpale skin, constipation, depression, irritability, memory loss, abnormalmenstrual cycles, decreased libido

    in an infant: cretinism-- stunted growth, mental retardation, abnormal boneformation

    Hashimotos disease: when hypothyroidism is due to an autoimmuneproblem (autoantibodies attack and destroy follicular cells)

    goiterno T3 and T4 can be made because not enough iodides wereingested.

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    59/92

    60

    Pr imary Hypothy ro id ism (Myxedema)

    -When synthesis of T3/T4 is low, no feedbackinhibition of TSH occurs and TSH levels rise.

    -TSH stimulation of the thyroid gland is

    increased and lead to:

    -the lack of T3/T4 synthesisin primary hypothyroidism leads to

    TSH-mediated increases in size (goiter).

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    60/92

    61

    When the pituitary can't make TSH

    there is no signal to the thyroid gland

    to make T3/T4. Thus secondary

    hypothyroidism is (i.e. pituitary-

    mediated) associated with decreasedT3/T4 AND TSH and thyroid atrophy.

    Secondary Hypothyro id ism

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    61/92

    62

    Primary hyperthyroidism: Thyroidsecretes T3/T4 in a TSH unregulated

    fashion

    Symptoms:

    -heart palpitations, heat intolerance,

    nervousness, insomnia, breathlessness,

    increased bowel movements, light/absent

    menstrual periods and fatigue

    Primary Hyperthyroidism

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    62/92

    63

    Loss of T3/T4-mediated negative

    effects on TSH release by pituitary

    -the thyroid is chronically stimulatedto synthesize and secrete T3/T4

    and to grow. Thus ,goiter is also a

    symptom of secondary

    hyperthyroidism

    Secondary Hyperthyroidism

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    63/92

    64

    Relief of direct symptoms: Drugs that inhibit thyroid hormone

    production/release (methimazole, propylthiouracil (PTU):

    -Inhibit hrmone synthesis (iodine organification)

    -Inhibit MIT coupling

    Limitations: The symptoms associated with hyperthyroidism return

    when the drugs are discontinued.

    Hyperthyroidism-Treatments

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    64/92

    65

    Radioactive Iodine:[135I]-most widely recommended permanent treatment of

    hyperthyroidism

    -treatment takes advantage of the fact that only thyroid cellscan incorporate iodine

    -[135I] emits gamma () radiation: Directly kills thyroid cells

    -There is no evidence that [135I] treatment for hyperthyroidism

    causes cancer of the thyroid gland or of any other tissue

    Hyperthyroidism-Treatments

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    65/92

    66

    BUT IS CALCITONIN AN IMPORTANT PHYSIOLOGICAL SUBSTANCE?

    The observation that calcitonin (CT) at supraphysiological doses is hypocalcemic, led to the mistaken

    conclusion that it was important for calcium homeostasis and this idea has persisted to this day.

    Despite these findings there is no apparent pathology due to CT excess or deficiency and there is no

    evidence that circulating CT is of substantial benefit to any mammal.

    Mammalian CT at physiological doses is not essential and very likely the CT gene has survived

    because of the genes alternate mRNA pathway to produce calcitonin-gene-related peptide CGRP

    found in neural tissues.

    HIRSCH,PF and BARUCH H, ENDOCRINE 2003, 201-208

    CALCITONIN IS SECRETED FROM THE THYROID PARAFOLLICULAR CELLS

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    66/92

    67

    THE PARATHYROID HORMONE

    Parathyroid Gland

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    67/92

    68

    Parathyroid Gland

    This gland only secretes

    one hormone:

    Parathyroid Hormone(or PTH)

    PTH function (we began

    learning this when we

    studied bone):

    increases bloodcalcium (Ca2+) levels

    and decreases

    blood phosphate

    (PO42-) levels

    PTH function (cont inued)

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    68/92

    69

    PTH function (cont inued)

    How does PTH work?

    PTH causes Ca2+ & PO42- to be released from

    bone into blood (by increasing osteoclast

    activity)

    PTH decreases the excretion of PO42- ionsthrough urine

    PTH increases calcitriol production, so that more

    Ca2+ is absorbed during digestion

    PTH is regulated by blood calcium levels-- not by

    other glands!

    The Regulation of Calcium Ion Concentrations

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    69/92

    70Figure 18.15

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    70/92

    71

    THE PANCREATIC HORMONES

    The pancreatic islets

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    71/92

    72

    Clusters of endocrine cells within the

    pancreas called Islets of Langerhans or

    pancreatic islets Alpha cells secrete glucagons

    Beta cells secrete insulin

    Delta cells secrete GH-IH F cells secrete pancreatic polypeptide

    The pancreatic islets

    The Endocrine Pancreas

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    72/92

    73

    The Endocrine Pancreas

    Figure 18.18a, b

    BLOOD FLOWS RADIALLY FROM CENTER OF ISLET

    ISLETS OF LANGERHANS

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    73/92

    74

    BLOOD FLOWS RADIALLY FROM CENTER OF ISLETTO THE PERIPHERY FACILITATING PARACRINE

    INHIBITION OF GLUCAGON SECRETION BY INSULIN

    VENOUS BLOOD

    MANTLE FORMED BY CELLSSECRETING GLUCAGON (20-25%)

    CORE FORMED BY BETA CELLS

    SECRETING INSULIN(60-70 % OF TOTAL)

    1 MILLION ISLETS EACH

    CONTAINING 2500 CELLS

    ARTERIAL BLOOD

    VENOUS BLOOD

    CELL CELLSECRETORY

    GRANULES

    Canaliculus

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    74/92

    75

    Endocrine Pancreas

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    75/92

    76

    Endocrine Pancreas

    Insulin

    Synthesized from proinsulin

    Secretion is promoted by blood

    glucose

    Facilitates the rate of glucose uptake

    into the cells

    Anabol ic hormone

    Synthesis of proteins, lipids

    and nucleic acids

    E d i P

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    76/92

    77

    Endocrine Pancreas

    Glucagon

    Secretion is promoted by decreased

    blood glucose levels

    Stimulates glycogenolysis,gluconeogenesis and lipolysis

    Somatostatin (delta cells)

    Regulation alpha and beta cellsecretions

    PHYSIOLOGICAL ROLE OF INSULIN

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    77/92

    78

    MAINTENANCE OF NORMAL PLASMA GLUCOSE LEVELS IN

    SPITE OF LARGE CHANGES DUE TO FOOD INTAKE

    PRESERVATION OF ENERGY STORES

    STIMULATION OF GLUCOSE TRANSPORT

    STIMULATION OF GLUCOSE UTILIZATION

    RAPID UPTAKE OF DIETARY GLUCOSE

    UTILIZATION OF DIETARY GLUCOSE

    STIMULATION OF GLUCOSE OXIDATION

    STIMULATION OF LIPID SYNTHESIS

    STIMULATION OF GLYCOGEN SYNTHESIS

    INHIBITION OF GLYCOGEN DEGRADATION

    INHIBITION OF GLUCONEOGENESIS

    INHIBITION OF LIPOLYSIS

    INHIBITION OF PROTEOLYSIS

    Endocrine Pancreas

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    78/92

    79

    Endocrine Pancreas

    Figure 18.19 The Regulation of Blood Glucose

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    79/92

    80Figure 18.19

    Figure 18.19 The Regulation of Blood Glucose

    Concentrations

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    80/92

    81

    THE PINEAL GLAND

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    81/92

    82

    Pineal Gland

    Secretes only one hormone: melatonin

    - involved in your circadian rhythm (your recognition of day and

    night times):

    melatonin secretion decreases in the day

    melatonin secretion increases at night

    Melatonin is also involved in longer rhythms, like monthly and

    seasonal

    - inhibits reproductive function

    - protects against damage by free radicals

    - has anti-ageing, anti-cancer effects

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    82/92

    83

    The Endocrine Functions of Other

    Organs

    The intestines

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    83/92

    84

    Produce hormones important to the

    coordination of digestive activities

    The kidneys

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    84/92

    85

    Produce calcitriol and erythropoietin (EPO) and theenzyme rennin

    Calcitriol = stimulates calcium and phosphate ion

    absorption along the digestive tract

    EPO stimulates red blood cell production by bonemarrow

    Renin converts angiotensinogen to angiotensin I

    y

    Angiotensin I converted to angiotensin II in

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    85/92

    86

    Stimulates adrenal production of aldosterone

    Stimulates pituitary gland release of ADH

    Promotes thirst Elevates blood pressure

    the lungs

    Endocrine Functions of the Kidneys

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    86/92

    87

    Endocrine Functions of the Kidneys

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    87/92

    88

    LUNGS

    The heart

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    88/92

    89

    Specialized muscle cells produce natriuretic

    peptides when blood pressure becomes excessive

    Generally oppose actions of angiotensin II

    The thymus

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    89/92

    90

    Produces thymosins

    help develop and maintain normal

    immune defenses are involved in white blood cell production

    y

    Adipose tissues secrete

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    90/92

    91

    Leptin, a feedback control for appetite

    Resistin, which reduces insulin sensitivity

    p

    The gonads

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    91/92

    92

    g

    Interstitial cells of the testes

    produce testosterone Most important sex hormone

    in males

    In females, oocytes develop in

    follicles Follicle cells produce

    estrogens

    After ovulation, the follicle cells

    form a corpus luteum thatreleases a mixture of estrogens

    and progesterone

  • 7/27/2019 mechanism hormone disease (lec 3).ppt

    92/92

    I fought the law, but the law won..